Navigation Links
AstraZeneca Joins Local Walking Movement

- Philly-Area Employers Get Moving by Putting on Their Walking Shoes -

PHILADELPHIA, Sept. 14 /PRNewswire-USNewswire/ -- AstraZeneca continues its fight against sedentary lifestyles by participating in the American Heart Association (AHA)'s Start! movement in Philadelphia to promote walking and other healthy habits in the workplace. AstraZeneca employees in Philadelphia have formed a Start! "walkforce" team to participate in today's Philadelphia Start! Heart Walk at Citizens Bank Park. Start! encourages Americans and their employers to live longer, stronger and healthier lives by engaging in regular physical activity. AstraZeneca, with U.S. headquarters in Wilmington, DE, is one of three national sponsors of Start! and has been recognized as a leader for supporting innovative corporate wellness initiatives.

"Because heart disease is the nation's number-one killer and the leading cause of death in Pennsylvania, we are building on AstraZeneca's strong legacy in cardiovascular treatments by leading this movement to help the Philadelphia community get moving," said Lisa Davis, AstraZeneca Vice President Corporate Communications and the company's Philadelphia Start! leader. "As a healthcare company dedicated to improving the health of people globally, the job starts locally with our own employees. We challenge other corporations in the Philadelphia area to join us as part of the Start! movement and make a commitment to wellness."

AstraZeneca is also the national sponsor of the Create Hope Community, part of the Heart Healthy festivities following the Philadelphia Start! Heart Walk. The exhibit provides walkers with an interactive and personalized health experience, offers free blood pressure and cholesterol screenings, educational health information, and tools to promote healthier lifestyles.

AstraZeneca encourages employees to incorporate exercise into their workday with lunch time walking programs and access to onsite fitness facilities. At its U.S. headquarters, the company has built indoor and outdoor walking paths and offers employees nutritious food options in the cafeterias on campus, as well as the availability of nutrition counselors.

Heart disease is the number-one killer in the United States,(1) and physical inactivity may increase a person's heart disease risk.(2) Pennsylvania accounted over 25% of its deaths due to cardiovascular disease in 2004 (the most recent year for which data are available).(3) Walking is one of the simplest ways people can improve their heart health -- it's free, it has the lowest drop-out rate of any physical activity and just one hour a day can add two hours to a person's life.(4) Moreover, American employers pay an estimated $225.8 billion each year in health-related productivity losses. Incorporating walking into every work day can help change these alarming statistics, while also helping contain rising health care costs.

About Start!

Start! Walking Program is the American Heart Association's ground-breaking national movement that calls on all Americans and their employers to promote a culture of physical activity and health in order to live longer, healthier lives. Through the Start! Fit-Friendly Companies Recognition Program, AHA recognizes employers who champion the health of their employees and work to create a culture of physical activity and health in the workplace. The program recognizes and rewards companies for progressive leadership and for making the health and wellness of their staff a priority. The program is also meant to encourage other companies to participate and demonstrate similar physical activity practices for their employees. For a list of recognized companies, visit

About AstraZeneca

AstraZeneca is a major international healthcare business engaged in the research, development, manufacture and marketing of prescription pharmaceuticals and the supply of healthcare services. It is one of the world's leading pharmaceutical companies with healthcare sales of $26.47 billion and leading positions in sales of gastrointestinal, cardiovascular, neuroscience, respiratory, oncology and infection products. AstraZeneca is listed in the Dow Jones Sustainability Index (Global) as well as the FTSE4Good Index.

In the United States, AstraZeneca is a $12.44 billion healthcare business with more than 12,000 employees. For nearly three decades, AstraZeneca has offered drug assistance programs side by side with its medicines, and over the past five years, has provided over $3 billion in savings to more than 1 million patients throughout the U.S. and Puerto Rico. AstraZeneca has been named one of the "100 Best Companies for Working Mothers" by Working Mother magazine and is the only large pharmaceutical company named to FORTUNE magazine's 2007 list of "100 Best Companies to Work For." In 2006, for the fifth consecutive year, Science magazine named AstraZeneca a "Top Employer" on its ranking of the world's most respected biopharmaceutical employers.

To join AstraZeneca and the American Heart Association for the Philadelphia Start! Heart Walk, please e-mail: To learn more about AstraZeneca, visit

(1) American Heart Association. Heart Disease Facts. accessed on 11.19.06

(2) Centers for Disease Control and Prevention DHDSP - Heart Disease Risk


accessed on 4.26.07

(3) Pennsylvania State Department of Health; Heart Disease and Stroke

Program. Heart Disease in Pennsylvania

accessed on 8.07.07

(4) American Heart Association. Moving for Individuals. accessed on 11.18.06

SOURCE AstraZeneca
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Astrazenecas Investigational Cancer Therapies Revealed at ASCO
2. Ranbaxy joins hand with Cipla to co-market ciprofloxacin
3. Rat joins list of cloned animals
4. Richard Gere Joins Indian Stars For Fight Against AIDS
5. Enbrel Joins with Methotrexate to Cure Rheumatoid Arthritis
6. Anoushka Joins Hands With WFP to Feed the Poor
7. India Joins Hands With Global Body for Vaccine Research
8. Another Statewide Organization Joins the Fight Against Assisted Suicide
9. Two-year-old Joins Mensa, Becomes Its Youngest Ever Genius
10. A Novel Method Of Detection Of High Nuclear Grade Localized Renal Cell Carcinoma
11. Residential Locality, A New Determinant Factor For Weight Gain
Post Your Comments:
(Date:6/27/2016)... ... June 27, 2016 , ... A revolution is underway. ... ambulance transport experience for the millions of people who require these medical transport ... taxi industry through the use of technology. Now, SmartEMS has put forth an ...
(Date:6/26/2016)... ... June 26, 2016 , ... Pixel Film Studios Released ... , "Film editors can give their videos a whole new perspective by using the ... CEO of Pixel Film Studios. , ProSlice Levels contains over 30 Different presets ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the ... several important health care topics including advance care planning, healthcare costs and patient ...
(Date:6/25/2016)... ... , ... First Choice Emergency Room , the largest network of independent ... Director of its new Mesquite-Samuell Farm facility. , “We are pleased to announce ... Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits ... terms of the latter, setting the bar too high can result in disappointment, perhaps ... slow progress toward their goal. , Research from reveals that ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Research and Markets has announced ... Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality ... - Global Forecast to 2021" report to their ... global pharmaceutical excipients market is projected to reach USD ... in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that it ... (procalcitonin) assay as a dedicated testing solution for people ... Roche is the first IVD company in the U.S ... assessment and management. PCT is a sepsis-specific ... blood can aid clinicians in assessing the risk of ...
(Date:6/23/2016)... ANGELES , June 23, 2016 ... CAPR ), a biotechnology company focused ... therapeutics, today announced that patient enrollment in its ... in Duchenne) has exceeded 50% of its 24-patient ... enrollment in the third quarter of 2016, and ...
Breaking Medicine Technology: